(Q36225561)

12 August 2017

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist (English)

1 reference

12 August 2017

D K Von Lubitz

1

1 reference

12 August 2017

R C Lin

2

1 reference

12 August 2017

N Bischofberger

3

1 reference

12 August 2017

M Beenhakker

4

1 reference

12 August 2017

M Boyd

5

1 reference

12 August 2017

R Lipartowska

6

1 reference

12 August 2017

K A Jacobson

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

European Journal of Pharmacology

12 August 2017

1 reference

12 August 2017

369

1 reference

12 August 2017

3

1 reference

12 August 2017

313-317

1 reference

Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine receptor ligands: differences with acute versus chronic treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine A3 receptor stimulation and cerebral ischemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine: a prototherapeutic concept in neurodegeneration.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Probing the adenosine receptor with adenosine and xanthine biotin conjugates

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine and brain ischemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438899

Differential desensitization of A1 adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity. Relation to the regulation of receptor affinity and density

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900073-4

Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900073-4

10.1016/S0014-2999(99)00073-4

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

10225368

1 reference